Nebraska Methodist Hospital Cancer Center — Omaha, Nebraska

Nebraska Methodist Hospital Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Hospital Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer, Hormone Refractory Prostate Cancer.

Sponsors: Agennix.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Hospital Cancer Center?

Nebraska Methodist Hospital Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Hospital Cancer Center conducted?

Nebraska Methodist Hospital Cancer Center has 1 clinical trials on record. Their work covers Prostate Cancer, Hormone Refractory Prostate Cancer.

Is Nebraska Methodist Hospital Cancer Center accredited by Crixeo Health?

Nebraska Methodist Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.